Teva Pharmaceutical (TEVA)

Teva Pharmaceutical Stock Analysis & Ratings

TEVA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$7.23 - $10.50
Previous Close$8.21
Average Volume (3M)9.46M
Market CapN/A
Enterprise ValueN/A
P/E Ratio-14.8
Next EarningsAug 04, 2022
Dividend YieldN/A
Smart Score5



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Teva Pharmaceutical’s price range in the past 12 months?
Teva Pharmaceutical lowest stock price was $7.23 and its highest was $10.50 in the past 12 months.
    What is Teva Pharmaceutical’s market cap?
    Currently, no data Available
    What is Teva Pharmaceutical’s price target?
    The average price target for Teva Pharmaceutical is $9.60. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $13.00 ,the lowest forecast is $7.00. The average price target represents 22.61% Increase from the current price of $7.83.
      What do analysts say about Teva Pharmaceutical?
      Teva Pharmaceutical’s analyst rating consensus is a ‘Hold. This is based on the ratings of 5 Wall Streets Analysts.
        When is Teva Pharmaceutical’s upcoming earnings report date?
        Teva Pharmaceutical’s upcoming earnings report date is Aug 04, 2022 which is in 36 days.
          How were Teva Pharmaceutical’s earnings last quarter?
          Teva Pharmaceutical released its earnings results on May 03, 2022. The company reported $0.55 earnings per share for the quarter, beating the consensus estimate of $0.549 by $0.001.
            Is Teva Pharmaceutical overvalued?
            According to Wall Street analysts Teva Pharmaceutical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Teva Pharmaceutical pay dividends?
              Teva Pharmaceutical pays a Quarterly dividend of $0.07 which represents an annual dividend yield of N/A. Teva Pharmaceutical’s last Quarterly dividend payment was on Dec 12, 2017. Teva Pharmaceutical’s upcoming ex-dividend date is Nov 27, 2017
                What is Teva Pharmaceutical’s EPS estimate?
                Teva Pharmaceutical’s EPS estimate is $0.56.
                  How many shares outstanding does Teva Pharmaceutical have?
                  Teva Pharmaceutical has 1,110,352,400 shares outstanding.
                    What happened to Teva Pharmaceutical’s price movement after its last earnings report?
                    Teva Pharmaceutical reported an EPS of $0.55 in its last earnings report, beating expectations of $0.549. Following the earnings report the stock price went up 0.821%.
                      Which hedge fund is a major shareholder of Teva Pharmaceutical?
                      Among the largest hedge funds holding Teva Pharmaceutical’s share is Abrams Capital Management L.P.. It holds Teva Pharmaceutical’s shares valued at 226M.


                        Teva Pharmaceutical Stock Analysis

                        Smart Score
                        Price Target
                        ▲(22.61% Upside)
                        The Teva Pharmaceutical stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description

                        Teva Pharmaceutical

                        Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

                        Similar Stocks
                        Price & Change
                        Sanofi-Aventis Sa
                        Fortress Biotech
                        Eagle Pharmaceuticals

                        Popular Stocks

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis